Clinical Trial Update: Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports efficacy, immunogenicity, and safety findings for a single-dose Staphylococcus aureus vaccine (V710) in adults scheduled for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Mediastinitis
• Staphylococcus Aureus Infection

Drugs mentioned

• V710 (V710 vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Staphylococcus Aureus, Bacteremia | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2012-11-05